共查询到20条相似文献,搜索用时 125 毫秒
1.
综合性肺康复治疗对稳定期COPD患者肺功能及血气指标的影响 总被引:2,自引:0,他引:2
将同期收治的60例慢性阻塞性肺疾病(COPD)稳定期患者随机分为观察组和对照组各30例,两组均予COPD基础治疗,观察组在此基础上给予呼吸功能锻炼、呼吸体操、有氧训练、氧疗、营养支持、心理与行为干预和教育等综合性肺康复治疗,观察两组肺功能及血气指标变化。结果观察组治疗前、后肺功能及血气指标均明显改善,效果优于对照组(P〈0.05)。认为综合性肺康复治疗有利于提高稳定期COPD患者的生存质量。 相似文献
2.
目的 探讨综合肺康复护理对稳定期慢性阻塞性肺疾病(COPD)患者运动耐力及生活质量的影响。方法 纳入2019年9月至2020年12月我院老年科收治的84例稳定期COPD患者作为研究对象,随机分为对照组和观察组,各42例。对照组接受常规护理,观察组在此基础上实施综合肺康复护理。比较两组患者干预前后6分钟步行试验(6MWT)距离、Borg呼吸困难评分及慢性阻塞性肺疾病评估测试(CAT)评分的变化情况。结果 观察组患者干预后6MWT距离高于对照组,观察组患者干预后Borg呼吸困难评分、CAT评分低于对照组,数据间差异均有统计学意义(P<0.05)。结论 综合肺康复护理干预能够有效提升稳定期COPD患者的运动耐力,改善生活质量。 相似文献
3.
目的 探讨肺康复运动治疗对老年慢性阻塞性肺疾病(COPD)稳定期患者肺功能、生活质量及运动耐力的影响。方法 选择老年COPD稳定期患者94例,依据随机表法分为观察组与对照组各47例。对照组采用常规有氧运动,观察组在对照组基础上结合肺康复运动治疗。两组干预时间3个月。比较两组干预前与干预3个月肺功能[用力肺活量(FVC)、每分钟最大通气量(MV)、1 s用力呼气容积(FEV1)/FVC]、BODE指数(B:体重指数、O:气道阻塞程度、D:呼吸困难分级、E:运动耐量)、运动耐力[6 min步行距离(6MWD)]、血气分析[氧分压(PaO2)、二氧化碳分压(PaCO2)]和生活质量[COPD临床问卷(CCQ)评分]变化。结果 两组干预3个月FVC、MVV和FEV1/FVC显著高于干预前(P<0.05);且观察组显著高于对照组(P<0.05)。两组干预3个月BODE指数显著低于干预前(P<0.05);且观察组显著低于对照组(P<0.05)。两组干预3个月6MWD显著高于干预前(P<0.05);且观察组显著高于对照组(P&... 相似文献
4.
目的:探讨以肺康复为主的综合管理康复治疗对稳定期 COPD患者的价值。方法选取2014年3月至2015年8月本院呼吸内科达到出院标准的70例稳定期COPD患者,采用随机数字表法分为研究组和对照组各35例,2组出院时均给予常规医嘱用药,研究组同时在研究人员的指导下进行以肺康复为主的综合管理康复治疗,干预时间6个月。结果干预前,研究组和对照组的 FEV1、FEV1%pred、6分钟步行距离、慢性阻塞性肺疾病自我评估测试(CAT)评分、呼吸困难指数(mMRC)评分、BODE指数差异均无统计学意义(P >0.05);干预12周、干预结束时,研究组的FEV1、FEV1%pred、6分钟步行距离均显著的高于对照组(P <0.05),研究组的 CAT 评分、mMRC评分、BODE指数均显著的高于对照组(P <0.05)。干预期间,研究组平均 AECOPD 次数[(0.59±0.22)次]显著的低于对照组的次数[(0.92±0.30)次](t=5.928,P<0.05)。结论以肺康复为主的综合管理康复治疗措施能够改善COPD患者的肺功能及生活质量,减少 AECOPD次数。 相似文献
5.
6.
7.
8.
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是指气流阻塞特征的慢性支气管炎或(和)肺气肿,气流阻塞进行性发展,但部分有可逆性,可伴气道高反应性,后期可并发慢性肺源性心脏病。COPD其病情的进展快慢很大程度上取决于是否进行有效的肺康复治疗。目前我国对COPD常常只注重急性发作期的治疗而忽视缓解期的康复治疗,为此就稳定期COPD患者肺康复治疗进行综述。 相似文献
9.
慢性阻塞性肺疾病(COPD)是一种可以预防和可以治疗的常见疾病,气流受限呈进行性发展,伴有气道和肺对有害颗粒或气体所致慢性炎症反应的增强。气流受限不完全可逆,导致肺功能逐渐减退,严重影响患者的健康和生活质量。但目前多数医生和患者本人对COPD急性加重期的病情控制较重视,而对其稳定期的康复治疗和管理却忽视大意,以致造成急性加重 相似文献
10.
目的探讨慢性阻塞性肺疾病(COPD)患者稳定期的康复治疗方法。方法选择临床确诊的COPD患者,随机分为两组,治疗组(A组)进行康复及对症治疗;对照组(B组)仅对症治疗。随访2年,观察每月肺功能、动脉血气及2年发病次数。结果A组治疗后肺功能等各项指标均显著改善优于对照组,且每年发作频率明显减少。结论康复综合治疗可改善COPD患者的呼吸功能,提高生活质量,减少发作次数,减轻经济负担,值得推广。 相似文献
11.
12.
Stickland M Jourdain T Wong EY Rodgers WM Jendzjowsky NG Macdonald GF 《Canadian respiratory journal》2011,18(4):216-220
BACKGROUND:
Pulmonary rehabilitation (PR) is an effective therapeutic strategy to improve health outcomes in patients with chronic obstructive pulmonary disease (COPD); however, there is insufficient PR capacity to service all COPD patients, thus necessitating creative solutions to increase the availability of PR.OBJECTIVE:
To examine the efficacy of PR delivered via Telehealth (Telehealth-PR) compared with PR delivered in person through a standard outpatient hospital-based program (Standard-PR).METHODS:
One hundred forty-seven COPD patients participated in an eight-week rural PR program delivered via Telehealth-PR. Data were compared with a parallel group of 262 COPD patients who attended Standard-PR. Education sessions were administered two days per week via Telehealth, and patients exercised at their satellite centre under direct supervision. Standard-PR patients viewed the same education sessions in person and exercised at the main PR site. The primary outcome measure was change in quality of life as evaluated by the St George’s Respiratory Questionnaire (SGRQ). A noninferiority analysis was performed using both intention-to-treat and per-protocol approaches.RESULTS:
Both Telehealth-PR and Standard-PR resulted in clinically and statistically significant improvements in SGRQ scores (4.5±0.8% versus 4.1±0.6%; P<0.05 versus baseline for both groups), and the improvement in SGRQ was not different between the two programs. Similarly, exercise capacity, as assessed by 12 min walk test, improved equally in both Telehealth-PR and Standard-PR programs (81±10 m versus 82±10 m; P<0.05 versus baseline for both groups).CONCLUSION:
Telehealth-PR was an effective tool for increasing COPD PR services, and demonstrated improvements in quality of life and exercise capacity comparable with Standard-PR. 相似文献13.
14.
Shahin Barakat Germain Michele Pastene George Viallet Nicole Annat Guy 《INT J CHRONIC OBSTR》2008,3(1):155-162
Objective
To evaluate an entirely outpatient-based program of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease COPD, using St.George’s Respiratory questionnaire (SGRQ), the 6-minutes walking test (6-MWT) and BODE index as the primary outcome measures.Methods
A prospective, parallel-group controlled study of an outpatient rehabilitation program in 80 patients with COPD (67 men and 13 women; mean age 64.8 ± 10.6 years; FEV1, 42.8% ± 7.6% of the predicted value. The active group (n = 40) took part in a 14-week rehabilitation program [3 h/wk, 1.5 h of education and exercise and 1.5 h of cycling]. The control group (n = 40) was reviewed routinely as medical outpatients. The following evaluations were carried out at study entry and after14 weeks: (1) pulmonary function studies; (2) 6-minutes walking test 6MWT; (3) quality of life; and (4) BODE index.Results
The following patients completed the study: 35 patients (87.5%) from the active group (mean age, 63.7 ± 11.9 years; mean forced expiratory volume in one second (FEV1), 41.9 ± 2.6% of the predicted value); and 36 patients (88%) from the control group (mean age, 65.9 ± 10.3 years; mean FEV1, 43.33 ± 3.6% of the predicted value). We found no changes in pulmonary function parameters in the active group and the control one at 14weeks. On the other hand, there were significant changes within the components of the SGRQ (12.3 for the score total) for the patients of the active group but not for the patients of the control one (only 1.5 for the score total), we observed also a significant increase in the distance of the 6-MWT in the patients of the active group but not for the patients of the control one, and finally a decrease of two points (from 6 to 4) was noted in the score of the active group’s BODE index without any change in the control group’s one.Conclusion
An outpatient-based of 14-week rehabilitation program significantly improved the quality of life and exercise tolerance without any change in the pulmonary function in patients with moderate COPD, and there was also a large decrease in the risk of death in rehabilitated patients as measured using the BODE index. 相似文献15.
孙大友 《中华肺部疾病杂志(电子版)》2011,4(1):52-55
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是以不完全可逆的气流受限且进行性发展为特征的疾病,是一种临床常见病,其发病率和病死率均在上升,预计到2020年,该病将成为全球第3位致死病因及第4位社会经济负担。 相似文献
16.
17.
18.
19.
The response to inhaled and oral steroids in patients with stable chronic obstructive pulmonary disease 总被引:1,自引:0,他引:1
Weiner P Weiner M Rabner M Waizman J Magadle R Zamir D 《Journal of internal medicine》1999,245(1):83-89
BACKGROUND: A significant minority of patients with COPD have favourable response to corticosteroid treatment. In addition, the benefit of corticosteroid treatment may be outweighed by the side-effects. Long-term administration of inhaled steroids is a safe means of treatment. However, only a few studies have addressed the role of inhaled steroids in patients with COPD, with conflicting results. METHODS: Forty-four patients with stable COPD were defined as 'responders to bronchodilators' (increase in FEV1 > or = 20% following administration of beta 2-agonist) (group A), and 124 as 'non-responders to bronchodilators' (group B). All patients were randomized to receive a 6-week course of either a daily dose of 800 micrograms of inhaled budesonide or placebo, separated by 4 weeks when no medication was taken; were randomized again to receive a 6-week course of either 1600 micrograms day-1 of inhaled budesonide, or 800 micrograms day-1 of inhaled budesonide plus placebo; and were randomized once again to receive a 6-week course of either 40 mg day-1 of prednisone or placebo. All stages were performed in a double-blind cross-over design. RESULTS: Following administration of 800 micrograms day-1 of inhaled budesonide, there was an increase in the mean FEV1 from 1.40 +/- 0.20 to 1.92 +/- 0.22 L (P < 0.001) and a significant decrease in inhaled beta 2 agonist consumption in group A. These changes remained almost stable during the increased dose of inhaled budesonide or during prednisone treatment. The mean FEV1 did not change during the placebo period, or in group B in either treatments. CONCLUSIONS: Treatment with inhaled steroids improved spirometry data and inhaled beta 2-agonist consumption in about one-quarter of patients with stable COPD, and this rate increased to about three-quarters in patients who responded to beta 2-agonist inhalation. There was no additional benefit in using a higher dose of inhaled budesonide or prednisone. 相似文献
20.
目的分析稳定期慢阻肺疾病患者的HAD和CAT相关性。方法从740例稳定期慢阻肺患者中,通过问卷形式,统计患者HAD和CAT评分,对于符合HAD》11分,同时满足排除标准的患者在进行统计相关性分析。结果共有74人符合本次研究的规定,其焦虑、抑郁发病率为10%。当中,男性56人,年龄(67士12)岁,焦虑、抑郁发病率:9.6%;女性18人,年龄(75士10)岁,焦虑、抑郁发病率:11.25%。焦虑和抑郁评分作为因变量,通过Pearson分析:其中CAT组相关系数r分别为0.76、0.61,P0.01,提示CAT和HAD呈强正相关,年龄组r=0.243,P=0.062;r=0.156、P=0.189,和HAD无统计学意义;FEV_1组相关系数r=-0.3、P0.05;r=-0.25、P0.05,提示和HAD呈弱负相关。结论 CAT评分和HAD评分有着密切的关联,既可以通过它反应患者的焦虑、抑郁等心理状态,又能反应慢阻肺患者健康相关生活质量,临床上操作简单,同时患者接受度高。 相似文献